NDAINTRAVENOUSSOLUTION
Approved
May 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
INFUVITE ADULT (multiple vitamins injection) by Novartis. Approved for vitamin deficiency in adults, children aged 11, older receiving parenteral nutrition (). First approved in 2000.
Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
INFUVITE ADULT is a multiple vitamins injection administered intravenously as a solution to treat vitamin deficiencies in adults and children aged 11+, as well as older patients receiving parenteral nutrition. The product provides essential vitamins through direct IV infusion to bypass oral absorption limitations.
LOE Approaching
As LOE approaches with moderate competitive pressure (30), commercial teams should expect market consolidation and shifting focus to defensive strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on INFUVITE ADULT at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.